Extendicare Inc
TSX:EXE

Watchlist Manager
Extendicare Inc Logo
Extendicare Inc
TSX:EXE
Watchlist
Price: 22.36 CAD 0.58% Market Closed
Market Cap: 1.9B CAD

Wall Street
Price Targets

EXE Price Targets Summary
Extendicare Inc

Wall Street analysts forecast EXE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EXE is 23.72 CAD with a low forecast of 19.19 CAD and a high forecast of 26.25 CAD.

Lowest
Price Target
19.19 CAD
14% Downside
Average
Price Target
23.72 CAD
6% Upside
Highest
Price Target
26.25 CAD
17% Upside
Extendicare Inc Competitors:
Price Targets
EKH
Ekachai Medical Care PCL
9% Upside
CON
Concentra Group Holdings Parent Inc
44% Upside
RAINBOW
Rainbow Children's Medicare Ltd
19% Upside
300143
INKON Life Technology Co Ltd
28% Upside
CHG
Chularat Hospital PCL
38% Upside
PNTG
Pennant Group Inc
19% Upside
540975
Aster DM Healthcare Ltd
27% Upside
GPTHEALTH
GPT Healthcare Ltd
18% Upside

Revenue
Forecast

Revenue Estimate
Extendicare Inc

For the last 13 years the compound annual growth rate for Extendicare Inc's revenue is -3%. The projected CAGR for the next 4 years is 11%.

-3%
Past Growth
11%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Extendicare Inc

For the last 13 years the compound annual growth rate for Extendicare Inc's operating income is -1%. The projected CAGR for the next 4 years is 21%.

-1%
Past Growth
21%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Extendicare Inc

The compound annual growth rate of Extendicare Inc's net income for the next 4 years is 7%.

N/A
Past Growth
7%
Estimated Growth
Estimates Accuracy
40%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EXE's stock price target?
Price Target
23.72 CAD

According to Wall Street analysts, the average 1-year price target for EXE is 23.72 CAD with a low forecast of 19.19 CAD and a high forecast of 26.25 CAD.

What is Extendicare Inc's Revenue forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Extendicare Inc's revenue is -3%. The projected CAGR for the next 4 years is 11%.

What is Extendicare Inc's Operating Income forecast?
Projected CAGR
21%

For the last 13 years the compound annual growth rate for Extendicare Inc's operating income is -1%. The projected CAGR for the next 4 years is 21%.

What is Extendicare Inc's Net Income forecast?
Projected CAGR
7%

The compound annual growth rate of Extendicare Inc's net income for the next 4 years is 7%.

Back to Top